Last mentioned: Mar 24, 2026
Expected Data Readouts
Anticipated primary endpoint results for the ALTO-100 Phase 2b/3 study in MDD.
$120M Private Placement
CFO Nick Smith announces a major financing round to accelerate late-stage clinical programs.
Phase 2b Expansion
Company expands clinical trials for ALTO-100 targeting specific biotypes of depression.
Initial Public Offering
Alto Neuroscience goes public on the NYSE to fund its precision psychiatry platform.
Alto Neuroscience has successfully raised $120 million through a private placement financing to accelerate its clinical-stage pipeline of precision medicines for mental health. Led by CFO Nick Smith, the funding underscores investor confidence in the company's AI-driven approach to identifying biomarkers for psychiatric disorders.
This page surfaces every story mentioning Precision Psychiatry across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Precision Psychiatry was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |